| dc.contributor.author | Hamblin, Michael R. | |
| dc.contributor.author | Abrahamse, Heidi | |
| dc.date.accessioned | 2022-02-28T20:22:47Z | |
| dc.date.available | 2022-02-28T20:20:08Z | |
| dc.date.available | 2022-02-28T20:22:47Z | |
| dc.date.issued | 2018-08 | |
| dc.date.submitted | 2018-07 | |
| dc.identifier.issn | 0272-4391 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/140825.2 | |
| dc.language | en | |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.1002/ddr.21453 | en_US |
| dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
| dc.source | Wiley | en_US |
| dc.title | Can light-based approaches overcome antimicrobial resistance? | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Hamblin, Michael R. and Abrahamse, Heidi. 2018. "Can light-based approaches overcome antimicrobial resistance?." Drug Development Research, 80 (1). | en_US |
| dc.contributor.department | Harvard University--MIT Division of Health Sciences and Technology | |
| dc.relation.journal | Drug Development Research | en_US |
| dc.eprint.version | Author's final manuscript | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dspace.date.submission | 2022-02-10T18:00:41Z | |
| mit.journal.volume | 80 | en_US |
| mit.journal.issue | 1 | en_US |
| mit.license | OPEN_ACCESS_POLICY | |
| mit.metadata.status | Authority Work Needed | en_US |
